| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | JELLY / TOPICAL | NA | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | INSERT / VAGINAL | 54.21 mg | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | FILM, EXTENDED RELEASE / TRANSDERMAL | | 16 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | CAPSULE, EXTENDED RELEASE / ORAL | | 120 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE PARTICLES / ORAL | | 580 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | | 1116 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | | 992 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | | 144 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET / SUBLINGUAL | | 30 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, DELAYED RELEASE / ORAL | | 79 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| POLYDEXTROSE | POLYDEXTROSE | VH2XOU12IE | TABLET, FILM COATED / ORAL | | 18 mg | Exact identifier — unii candidate 3 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | SOLUTION / OPHTHALMIC | | 42 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | SUSPENSION, EXTENDED RELEASE / ORAL | | 474 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | CAPSULE, LIQUID FILLED / ORAL | | 101 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | POWDER, FOR SUSPENSION / ORAL | | 34 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | CAPSULE, COATED, EXTENDED RELEASE / ORAL | | 15 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | INJECTION / INTRAMUSCULAR | 0.59 %w/v | | Exact identifier — unii candidate 40 equally ranked IID candidates |
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | SUSPENSION / ORAL | | 900 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | LOTION / TOPICAL | | 80 mg | Exact identifier — unii candidate 26 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED / ORAL | | 176 mg | Exact identifier — unii candidate 26 equally ranked IID candidates |
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | CAPSULE / ORAL | | 5785 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | OINTMENT / TOPICAL | 15 %w/w | | Exact identifier — unii candidate 26 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SYSTEM / TOPICAL | | 54 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SHAMPOO / TOPICAL | 3 %w/w | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, EXTENDED RELEASE / ORAL | 119.7 mg | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET, EXTENDED RELEASE / ORAL | | 368 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / ORAL | NA | | Exact identifier — unii candidate 26 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET, DELAYED RELEASE PARTICLES / ORAL | | 70 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TROCHE / ORAL | | 300 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CAPSULE, EXTENDED RELEASE / ORAL | | 64 mg | Exact identifier — unii candidate 26 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION / ORAL | | 305 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | | 120 mg | Exact identifier — unii candidate 26 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET, FOR SUSPENSION / ORAL | | 462 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, CHEWABLE / ORAL | | 180 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | SUSPENSION / ORAL | | 148 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | | 21 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | SOLUTION / TOPICAL | NA | | Exact identifier — unii candidate 26 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GRANULE / ORAL | | 45 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TROCHE / ORAL | | 175 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET, ORALLY DISINTEGRATING / ORAL | | 71 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, CHEWABLE / ORAL | 11.8 mg | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CREAM / TOPICAL | 0.1 %w/w | | Exact identifier — unii candidate 27 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | | 690 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, DELAYED RELEASE / ORAL | | 713 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | SUSPENSION / OPHTHALMIC | | 14 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / VAGINAL | | 1088 mg | Exact identifier — unii candidate 26 equally ranked IID candidates |
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | SUSPENSION, EXTENDED RELEASE / ORAL | | 113 mg | Exact identifier — unii candidate 22 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, DELAYED RELEASE / ORAL | | 105 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | | 190 mg | Exact identifier — unii candidate 26 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SYRUP / ORAL | | 250 mg | Exact identifier — unii candidate 27 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | POWDER, FOR SUSPENSION / ORAL | 1203 mg/5ml | | Exact identifier — unii candidate 26 equally ranked IID candidates |
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | EMULSION / TOPICAL | NA | | Exact identifier — unii candidate 26 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, FOR SUSPENSION / ORAL | | 278 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | GRANULE / ORAL | | 202 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 45 mg | | Exact identifier — unii candidate 40 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | LOZENGE / ORAL | | 700 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, EXTENDED RELEASE / ORAL | | 5119 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE / ORAL | | 29520 mg | Exact identifier — unii candidate 28 equally ranked IID candidates |
| POVIDONE K30 | POVIDONE K30 | U725QWY32X | CAPSULE, DELAYED RELEASE / ORAL | | 227 mg | Exact identifier — unii candidate 40 equally ranked IID candidates |
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | LOTION / TOPICAL | 0.1 %w/w | | Exact identifier — unii candidate 27 equally ranked IID candidates |